MMP2 and neoplasm: Moreover, reduced MMP-2 release from cancer-associated fibroblasts after treatment with WIN 55-212.2 led to reduced invasion of prostate cancer cells, suggesting that cannabinoids inhibit invasion not only by direct action on tumour cells [143].